Title Assessment of Coronary atherosclerosis in patients with familialhypercholesterolemia by coronary computed tomography angiography

The aims of this study were 1) to determine whether the accumulation of coronary plaque burden assessed with coronary computed tomography angiography (CCTA) can predict future events, and 2) to estimate the onset and progression of coronary atherosclerosis in patients with familial hypercholesterolemia (FH). Consecutive 101 Japanese heterozygous FH patients (male=52, mean age=56±16 years, mean LDL-C=264±58 mg/dL) who underwent 64-detector row CCTA without known coronary artery disease were retrospectively evaluated by assigning a score (0-5) to each of 17 coronary artery segments according to the Society of Cardiovascular Computed Tomography guidelines. Those scores were summed and subsequently natural log-transformed. The periods to major adverse cardiac events (MACE) were estimated using multivariable Cox proportional hazards models. During the follow-up period (median 941 days), 21 MACE had occurred. Receiver-operating characteristic curve analyses identified a plaque burden score of 3.35 (raw score 28.5) as the optimal cutoff for predicting a worse prognosis. Multivariate Cox regression analysis identified the presence of a plaque score ≥ 3.35 as a significant independent predictor of MACE (HR=3.65; 95% CI 1.32 to 25.84, p<0.05). The regression equations were Y=0. 68X-15.6 (r=0.54, p<0.05) in male and Y=0. 74X-24.8 (r=0. 69, p<0. 05) in female heterozygous FH patients. In conclusion, coronary plaque burden identified in a noninvasive, quantitative manner was significantly associated with future coronary events in Japanese patients with heterozygous FH and that coronary atherosclerosis may start to develop, on average, at 23 and 34 years of age in male and female heterozygous FH patients, respectively.

[1]  S. Yamashita,et al.  Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation , 2015, European journal of preventive cardiology.

[2]  S. Achenbach,et al.  SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. , 2014, Journal of cardiovascular computed tomography.

[3]  M. Yamagishi,et al.  Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation. , 2014, Atherosclerosis.

[4]  M. Budoff,et al.  Coronary computed tomography as a cost-effective test strategy for coronary artery disease assessment - a systematic review. , 2014, Atherosclerosis.

[5]  F. Rybicki,et al.  Prognostic Value of Nonobstructive and Obstructive Coronary Artery Disease Detected by Coronary Computed Tomography Angiography to Identify Cardiovascular Events , 2014, Circulation. Cardiovascular imaging.

[6]  K. Hayashi,et al.  Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects , 2014, Heart and Vessels.

[7]  Ryan C. Butterfield,et al.  Association of cardiac events with coronary artery disease detected by 64-slice or greater coronary CT angiography: a systematic review and meta-analysis. , 2013, International journal of cardiology.

[8]  X. Alomar Serrallach,et al.  Coronary computed tomographic angiographic findings in asymptomatic patients with heterozygous familial hypercholesterolemia and null allele low-density lipoprotein receptor mutations. , 2013, The American journal of cardiology.

[9]  E. Sijbrands,et al.  The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia. , 2013, Atherosclerosis.

[10]  K. Hayashi,et al.  Altered Metabolism of Low-Density Lipoprotein and Very-Low-Density Lipoprotein Remnant in Autosomal Recessive Hypercholesterolemia: Results From Stable Isotope Kinetic Study In Vivo , 2012, Circulation. Cardiovascular genetics.

[11]  E. Sijbrands,et al.  CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia , 2011, Heart.

[12]  Mathias Prokop,et al.  Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. , 2008, Journal of the American College of Cardiology.

[13]  D. Berman,et al.  Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. , 2007, Journal of the American College of Cardiology.

[14]  A. Soutar,et al.  Mechanisms of Disease: genetic causes of familial hypercholesterolemia , 2007, Nature Clinical Practice Cardiovascular Medicine.

[15]  H. Mabuchi,et al.  Development of coronary heart disease in familial hypercholesterolemia. , 1989, Circulation.

[16]  R. Frye,et al.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. , 1975, Circulation.

[17]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[18]  N. Paul,et al.  Perioperative β-Blockers : Use With Caution Perioperative β Blockers in Patients Having Non-Cardiac Surgery : A Meta-Analysis , 2010 .

[19]  T. Farag,et al.  Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.